Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

NCT00131144 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

583

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: Octreotide Acetate in Microspheres 20 mg
DRUG: Octreotide Acetate in Microspheres
DRUG: Placebo

Sponsor

Novartis